Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherInvited Commentary

Nitrates and Viability: A Durable Affair

Roberto Sciagrà
Journal of Nuclear Medicine May 2003, 44 (5) 752-755;
Roberto Sciagrà
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

The relationship between nitrate administration and viability detection dates back many years. Already in the 1970s, various groups had demonstrated that an improvement in regional left ventricular function produced by the acute administration of nitrates was related to a subsequent favorable response after coronary bypass surgery (1,2). In particular, Helfant et al. (1) showed that 15 of 18 asynergic segments with improvement after sublingual nitroglycerin had a similar improvement after bypass grafting, whereas the 2 segments with persistent dysfunction after nitroglycerin were unchanged even after bypass surgery. Similarly, Chesebro et al. (2) observed a good correlation between the changes in wall thickening produced by sublingual nitroglycerin and those registered several months after bypass surgery. Giving a histologic substrate to these clinical observations, Bodenheimer et al. (3) detected a lower degree of fibrosis in the nitrate-responsive segments than in the other asynergic segments. To explain these data, various mechanisms of action were suggested. Certainly, nitrates positively affect the relationship between myocardial oxygen supply and demand, mainly through the reduction in preload and afterload of the ventricles (4). However, it was also suggested that at least part of this effect was caused by a direct action on coronary circulation, either by vasodilatation of stenoses or by redistribution of flow to the ischemic areas, particularly through collateral vessels (5,6). The role of collateral circulation was confirmed in animal experiments by Hisano et al., who demonstrated that the improvement in regional function under isosorbide dinitrate was related to the degree of development of collaterals (7). In humans, Fujita et al. (8) observed that in patients in whom the territory of a completely occluded left ventricular descending artery was supplied by a good collateral circulation, both global and regional function improved significantly after sublingual nitroglycerin, whereas no change was registered in the remaining patients with occlusion but without collaterals. In all the above studies, attention was given mainly to the functional changes induced by nitrate administration. However, in good agreement with the hypothesis of a direct action on coronary collateral circulation, Aoki et al. demonstrated that in collateral-dependent noninfarcted myocardium the acute administration of nitroglycerin reduced the extent and severity of the 201Tl myocardial perfusion defect induced by exercise (9).

In the second half of the 1980s, the concept of hibernating myocardium, that is, chronic regional asynergia of ischemic origin with reversible dysfunction after successful revascularization, was introduced and deeply modified the diagnostic approach to heart failure in patients with coronary artery disease (10). Perfusion/metabolism imaging with PET emerged as the most accurate test to detect viable hibernating myocardium and was found to be more reliable than stress-redistribution 201Tl myocardial perfusion scintigraphy (11). To overcome the limitations of stress-redistribution scans and because of the need to evaluate large numbers of patients, modifications of the standard 201Tl imaging protocol were proposed. Delayed redistribution (12), rest-reinjection (13), and rest-redistribution (14) were tested and had good results for viability detection. The possibility of using the acute effects of nitrate on coronary blood flow to improve the detection of viable hibernating myocardium was examined for the first time by He et al., who demonstrated the increase in 201Tl defect reversibility if the tracer was reinjected after isosorbide dinitrate administration (15). However, because all of the various protocols proposed for viability detection were effective, nitrate-enhanced imaging was not considered essential if 201Tl was chosen as the perfusion agent. In the case of 99mTc-labeled perfusion tracers, several early reports suggested an underestimation of myocardial viability in the standard resting images obtained using these agents (16,17). The imaging protocol modifications used for 201Tl imaging were hardly feasible with the 99mTc-labeled perfusion tracers, although resting 99mTc-sestamibi quantitative SPECT (18) and redistribution images (19) were reported to achieve quite good results. In contrast, the experimental data clearly showed that all 99mTc-labeled agents available for clinical use (99mTc-sestamibi, 99mTc-teboroxime, and 99mTc-tetrofosmin) were not just pure flow tracers but also required myocyte viability to be retained within the myocardium (20–22). Therefore, the use of nitrate enhancement appeared an attractive approach to improve their ability to recognize viable myocardium. Bisi et al. observed that stress defect reversibility in resting 99mTc-teboroxime images was greater after nitrate enhancement, with a closer agreement to 201Tl reinjection data (23). In patients with previous myocardial infarction, Galli et al. found a sizable decrease in resting 99mTc-sestamibi uptake defects after nitroglycerin administration in 20 of 36 subjects and correlated it with indexes of likely preserved viability (24). Finally, Bisi et al., using 99mTc-sestamibi SPECT, demonstrated for the first time a direct relationship between nitrate-induced improvement in myocardial perfusion and regional functional recovery after coronary revascularization (25). In a patient population with left ventricular dysfunction and coronary artery disease that underwent successful revascularization, 7 patients showed significant functional recovery in at least 1 dysfunctional coronary territory and 11 showed an unchanged wall motion pattern in all asynergic territories: In the first group a decrease in the extent of the baseline perfusion defect was observed after isosorbide dinitrate infusion (−37.4% ± 21.6%), whereas in the second group no change in perfusion defect extent was registered in nitrate-enhanced imaging (+5.8% ± 8.4%, P < 0.0005 vs. the first group). Since then, several articles have confirmed the reliability of nitrate 99mTc-sestamibi scintigraphy for the recognition of viable myocardium within dysfunctional segments and the prediction of regional functional recovery (26–29). Similarly, nitrate administration increased the rate of defect reversibility in 99mTc-tetrofosmin scintigraphy and improved its agreement with 201Tl (30,31). Even the use of 201Tl nitrate-enhanced imaging was confirmed to be helpful for viability detection (32).

Despite the general agreement that the results of nitrate-enhanced perfusion imaging for predicting regional improvement compare well with other established methods (33), a clear-cut demonstration of the effects of nitrate administration on coronary circulation in the setting of viable dysfunctional myocardium was still lacking. Using PET and 13NH3, Fallen et al. had demonstrated that the topical application of nitroglycerin produced a preferential increase in tracer retention in ischemic versus nonischemic segments (34). Their patient population, however, did not include patients with left ventricular dysfunction, and the segment characterization was based on a stress-induced 201Tl defect; thus, there was no clear relationship between a preferential nitrate-induced increase in coronary blood flow and myocardial viability. The study by Tadamura et al. (35) that appears in this issue of The Journal of Nuclear Medicine tries to fill this gap, examining the changes induced by the acute administration of nitroglycerin on coronary blood flow in different groups of myocardial segments classified on the basis of one of the currently used techniques for viability detection, that is, 201Tl rest-redistribution SPECT. The authors identify 4 groups of regions: segments with normal uptake, segments with reversible defect (ischemic), segments with mild-to-moderate fixed defect (viable), and segments with severe fixed defect (nonviable). Measuring the absolute myocardial blood flow with 15O-water, the authors observed a preserved myocardial blood flow in front of a decrease in systemic arterial pressure in the segments classified as either ischemic or viable; this result was produced by a selective decrease in coronary vascular resistance in these 2 groups of segments (from 141 ± 50 to 114 ± 29 mm Hg/[mL/min/g], P = 0.004, and from 165 ± 64 to 149 ± 60 mm Hg/[mL/min/g], P = 0.003, in the ischemic and in the viable segments, respectively). Conversely, both the normal segments and those with a persistent severe reduction in 201Tl uptake showed a decrease in myocardial blood flow after nitrate administration because the drop in arterial pressure was not compensated for by a reduction in coronary vascular resistance. These results are interesting because they are the first direct demonstration that the effects of acute nitrate administration on coronary blood flow are not only selective but also remarkably favorable for the detection of ischemic viable myocardium. Thus, Tadamura et al. give a physiopathologic support to the above-mentioned clinical studies reporting the accuracy of nitrate-enhanced imaging protocols for the issue of viability detection. However, various problems still remain.

First, and as recognized by the authors, the limitations of the study must be considered. The patient population is not one for which the issue of viability is of major clinical relevance because most patients had a normal or near-normal left ventricular function and only 9 of 23 patients had a left ventricular ejection fraction ≤ 40%. Also, the reference method used by Tadamura et al. (35) to define the viability status of the myocardial segments is not optimal. Although widely used in clinical practice, 201Tl rest-redistribution cannot be considered the ultimate standard of myocardial viability. In particular, the specificity of this technique is well known to be relatively low (33). It is reasonable to assume that at least part of the segments considered viable according to the rest-redistribution scan result were not liable to functionally improve after revascularization and were hence nonviable according to the prevailing notion. Furthermore, no functional correlates of 201Tl uptake have been examined, so that it is impossible to understand whether there is a relationship between degree of functional impairment and nitrate-induced changes in coronary vascular resistance. Certainly, these limitations in patient selection and study protocol do not cancel the value of the report by Tadamura et al. but require that further studies be performed in which myocardial blood flow measurement under nitrate is examined while taking into account both baseline regional function and its evolution after revascularization.

Other problems are related to the more general issue of the role of baseline resting hypoperfusion in determining reversible dysfunction of the myocardium. The demonstration that nitrates induce a decrease in coronary vascular resistance in viable segments agrees with the classic concept that reversible dysfunction is caused by a status of chronic hypoperfusion (10). This concept, however, is not unanimously accepted, and the possibility that reversible dysfunction is caused by a status of repeated stunning in the presence of a severe reduction in coronary reserve, but with preserved resting perfusion, must be considered (36). Most probably, there is a continuous spectrum of conditions ranging from true hibernation to minimal-threshold ischemia with repetitive stunning (37). It is reasonable to hypothesize that the role of nitrate imaging could be slightly different under these conditions. Particularly with 99mTc-labeled perfusion tracers, and so excluding the effects of redistribution, resting uptake should usually be preserved in the case of chronic stunning, similarly to what has been already demonstrated after acute myocardial infarction treated by effective reperfusion (38), whereas nitrate administration would be necessary to allow a recognizable uptake in segments with true hibernation. If this hypothesis were true, nitrate imaging could be useful not only to overcome the imaging limitations of nonredistributing 99mTc-labeled perfusion tracers but also to differentiate between the 2 different conditions of reversible ischemic dysfunction. This problem could have important clinical implications. For instance, a different time course of functional recovery after revascularization in hibernating versus stunned myocardium has been observed (39). Furthermore, it cannot be excluded that hibernation and chronic stunning have different prognostic implications.

Another point to be clarified is whether the response to nitrate administration could be helpful to differentiate between viable myocardium liable to functionally improve after revascularization versus partially preserved viability in the instance of nontransmural necrosis, which could be valuable to prevent ventricular remodeling but should not be expected to recover after revascularization (40). In other words, nitrate imaging could play a role in improvement of the specificity of myocardial perfusion SPECT for the issue of viability detection, at least in terms of recognition of reversible dysfunction.

In conclusion, the study by Tadamura et al. (35) gives important support to the use of nitrate-enhanced imaging for the detection of viable myocardium. At the same time, it also justifies the need for further studies to improve our knowledge of the different physiopathologic conditions that subtend the presence of ischemic and possibly reversible myocardial dysfunction. Nitrate-enhanced imaging could play an interesting role in this kind of study about myocardial viability. The story of this durable affair goes on.

Footnotes

  • Received Jan. 7, 2003; revision accepted Jan. 20, 2003.

    For correspondence or reprints contact: Roberto Sciagrà, MD, Nuclear Medicine Unit, Department of Clinical Physiopathology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy.

    E-mail: r.sciagra{at}dfc.unifi.it

REFERENCES

  1. ↵
    Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation. 1974;50:108–113.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Chesebro JH, Ritman EL, Frye RL, et al. Regional myocardial wall thickening response to nitroglycerin: a predictor of myocardial response to aortocoronary bypass surgery. Circulation. 1978;57:952–957.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Bodenheimer MM, Banka VS, Hermann GA, Trout RG, Pasdar H, Helfant RH. Reversible asynergy: histopathologic and electrographic correlations in patients with coronary artery disease. Circulation. 1976;53:792–796.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol. 1992;70:30B–42B.
    OpenUrlCrossRefPubMed
  5. ↵
    Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981;64:1089–1097.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Cohn PF, Maddox D, Holman BL, et al. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol. 1977;39:672–678.
    OpenUrlCrossRefPubMed
  7. ↵
    Hisano K, Tomoike H, Inoue T, Mohri M, Nakamura M. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model. J Pharmacol Exp Ther. 1989;248:1289–1296.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Fujita M, Yamanishi K, Hirai T, et al. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J. 1990;120:521–528.
    OpenUrlCrossRefPubMed
  9. ↵
    Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J. 1991;121:1361–1366.
    OpenUrlCrossRefPubMed
  10. ↵
    Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–221.
    OpenUrlCrossRefPubMed
  11. ↵
    Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol. 1987;10:557–567.
    OpenUrlPubMed
  12. ↵
    Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988;12:1456–1463.
    OpenUrlPubMed
  13. ↵
    Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141–146.
    OpenUrlPubMed
  14. ↵
    Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630–1641.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    He ZX, Darcourt J, Guignier A, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med. 1993;34:1472–1477.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Altehoefer C, Kaiser H-J, Dörr R, et al. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med. 1992;19:334–342.
    OpenUrlPubMed
  17. ↵
    Matsunari I, Fujino S, Taki J, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med. 1995;36:1961–1967.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994;89:2552–2561.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Maurea S, Cuocolo A, Soricelli A, et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med. 1995;36:1953–1960.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Beanlands RSB, Dawood F, Wen W-H, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990;82:1802–1814.
    OpenUrlAbstract/FREE Full Text
  21. Abraham SA, Mirecki FN, Levine D, Nunn AD, Strauss HW, Gewirtz H. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability. J Nucl Med. 1995;36:1062–1068.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Koplan BA, Beller GA, Ruiz M, et al. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med. 1996;37:1398–1402.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Bisi G, Sciagrà R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve Tc-99m-teboroxime perfusion defect reversibility. J Nucl Med. 1994;35:1274–1278.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol. 1994;74:843–848.
    OpenUrlCrossRefPubMed
  25. ↵
    Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol. 1994;24:1282–1289.
    OpenUrlPubMed
  26. ↵
    Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med. 1995;36:1945–1952.
    OpenUrlAbstract/FREE Full Text
  27. Li ST, Liu XJ, Lu ZL, et al. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol. 1996;3:457–463.
    OpenUrlCrossRefPubMed
  28. Sciagrà R, Bisi G, Santoro GM, et al. Comparison of baseline-nitrate technetium-99m-sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol. 1997;30:384–391.
    OpenUrlCrossRefPubMed
  29. ↵
    Baszko A, Blaszyk K, Cieslinski A, et al. 99Tcm-sestamibi tomoscintigraphy at rest and after nitrate administration in predicting wall motion recovery after revascularization. Nucl Med Commun. 1998;19:1141–1148.
    OpenUrlPubMed
  30. ↵
    Thorley PJ, Bloomer TN, Sheard KL, et al. The use of GTN to improve the detection of ischaemic myocardium using 99mTc-tetrofosmin. Nucl Med Commun. 1996;17:669–674.
    OpenUrlPubMed
  31. ↵
    Flotats A, Carriò I, Estorch M, et al. Nitrate administration to enhance detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med. 1997;24:767–773.
    OpenUrlPubMed
  32. ↵
    He ZX, Medrano R, Hays JT, et al. Nitroglycerine augmented 201Tl reinjection enhances detection of reversible myocardial hypoperfusion: a randomized, double-blind, parallel, placebo-controlled trial. Circulation. 1997;95:1799–1805.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of the currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451–1460.
    OpenUrlCrossRefPubMed
  34. ↵
    Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Garnett ES. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation. 1995;91:1381–1388.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Tadamura E, Mamede M, Kubo S, et al. The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT. J Nucl Med. 2003;44:745–751.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Vanoverschelde J-LJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513–1523.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Heusch G, Schulz R. Hibernating myocardium: new answers, still more questions! Circ Res. 2002;91:863–865.
    OpenUrlFREE Full Text
  38. ↵
    Santoro GM, Bisi G, Sciagrà R, Leoncini M, Fazzini PF, Meldolesi U. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol. 1990;15:301–314.
    OpenUrlCrossRefPubMed
  39. ↵
    Bax JJ, Visser FC, Poldermans D, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001;104:I-314–I-318.
  40. ↵
    Shirani J, Lee J, Quigg R, Pick R, Bacharach SL, Dilsizian V. Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardium. J Am Coll Cardiol. 2001;38:84–90.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 44, Issue 5
May 1, 2003
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nitrates and Viability: A Durable Affair
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Nitrates and Viability: A Durable Affair
Roberto Sciagrà
Journal of Nuclear Medicine May 2003, 44 (5) 752-755;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nitrates and Viability: A Durable Affair
Roberto Sciagrà
Journal of Nuclear Medicine May 2003, 44 (5) 752-755;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Effects of Medications on Myocardial Perfusion
  • Initial Infarct Size Predicts Subsequent Cardiac Remodeling in the Rat Infarct Model: An In Vivo Serial Pinhole Gated SPECT Study
  • Absolute Quantitation of Myocardial Blood Flow After Nitroglycerin and Ischemic Cardiomyopathy with a Low Ejection Fraction
  • Google Scholar

More in this TOC Section

  • Cellular Origin and Molecular Mechanisms of 18F-FDG Uptake: Is There a Contribution of the Endothelium?
  • Can Molecular Imaging Predict In-Stent Restenosis?
  • Transport of 99mTc-MAG3 via Rat Renal Organic Anion
Show more Invited Commentary

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire